StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
3090.TW$220.00+1.97%
Fair $220.00+0.0%

3090.TW

Nichidenbo Corporation

Technology / Electronic ComponentsTaiwan

$220.00

+4.50 (+1.97%)

Fairly Valued+0.0%Fair Value $220.00Fund rank 28/100 · Data gapFallback financials|
SA 55/C
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 22%

FCF escenarios

weak_data · normalized FCF $55.5M · quality 48.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 26/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

55/100

C

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 3090.TWLocal privado en este navegador · Nichidenbo Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$63.3B

P/E

40.6x

↑

EV/EBITDA

37.3x

↑

ROE

9.1%

↑

Gross Margin

16.4%

↓

Debt/Equity

0.27

↑
52-Week Range$220
$67$251

TradingView lightweight chart

3090.TW price, volumen y niveles de valoración

Último $233.50Periodo +1228.6%
Fair value: $220.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+14.6%

FCF CAGR

-61.1%

FCF margin

0.4%

FCF / Net income

0.04x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $15.73B · net income $1.25B · FCF $55.5M

2022-FY → 2025-FY

Gross margin

16.4%-0.6% pts

Operating margin

10.1%+1.6% pts

Net margin

8.0%-6.3% pts

FCF margin

0.4%-8.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$15.73B$15.73B$12.14B$10.66B$10.44B
Net Income$1.25B$1.25B$946.8M$706.3M$1.49B
EBITDA$1.75B$1.75B$1.34B$1.03B$1.10B
EPS——4.463.337.89
Gross Margin16.4%16.4%16.0%15.4%17.1%
Operating Margin10.1%10.1%9.2%8.2%8.5%
Net Margin8.0%8.0%7.8%6.6%14.3%
Balance Sheet
Debt/Equity0.270.270.350.250.18
Current Ratio1.471.47———
Cash Flow
Free Cash Flow$55.5M$55.5M$-160.5M$952.7M$945.8M
Returns
ROE9.1%9.1%14.3%11.3%22.5%
Valuation
P/E40.5940.5915.1817.276.81
EV/EBITDA37.2937.2911.8011.338.99
P/B4.584.582.181.951.53
Growth & Yield
Revenue Growth29.5%29.5%13.9%2.1%—
EPS Growth——33.9%-57.8%—
Dividend Yield2.1%2.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +213.0%

Total return

+213.0%

Start / end P/E

n/dx → n/dx

EPS bridge

4.46 → n/d

Residual

+210.9%

EPS growthn/d
Multiple reratingn/d
Dividend+2.1%
Residual / FX / buybacks / cross-term+210.9%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.